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Abstract
Background: Globally, 15 million neonates are born prematurely every year, over half in low income countries
(LICs). Premature and low birth weight neonates have a higher risk of intraventricular haemorrhage (IVH). There are
minimal data regarding IVH in sub-Saharan Africa. This study aimed to examine the incidence, severity and timing
of and modifiable risk factors for IVH amongst low-birth-weight neonates in Uganda.
Methods: This is a prospective cohort study of neonates with birthweights of ≤2000 g admitted to a neonatal unit
(NU) in a regional referral hospital in eastern Uganda. Maternal data were collected from interviews and medical
records. Neonates had cranial ultrasound (cUS) scans on the day of recruitment and days 3, 7 and 28 after birth.
Risk factors were tabulated and are presented alongside odds ratios (ORs) and adjusted odds ratios (aORs) for IVH
incidence. Outcomes included incidence, timing and severity of IVH and 28-day survival.
Results: Overall, 120 neonates were recruited. IVH was reported in 34.2% of neonates; 19.2% had low grade (Papile
grades 1–2) and 15% had high grade (Papile grades 3–4). Almost all IVH (90.2%) occurred by day 7, including 88.9%
of high grade IVH. Of those with known outcomes, 70.4% (81/115) were alive on day 28 and survival was not
associated with IVH. We found that vaginal delivery, gestational age (GA) < 32 weeks and resuscitation in the NU
increased the odds of IVH. Of the 6 neonates who received 2 doses of antenatal steroids, none had IVH.
Conclusion: In this resource limited NU in eastern Uganda, more than a third of neonates born weighing ≤2000 g
had an IVH and the majority of these occurred by day 7. We found that vaginal birth, earlier gestation and need for
resuscitation after admission to the NU increased the risk of IVH. This study had a high rate of SGA neonates and
the risk factors and relationship of these factors with IVH in this setting needs further investigation. The role of
antenatal steroids in the prevention of IVH in LICs also needs urgent exploration.
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Introduction
Globally, 15 million neonates are born prematurely every
year, with more than half being in low-income countries
(LICs) [1, 2]. With rising rates of preterm birth and de-
creasing mortality due to improved neonatal care, the
numbers of preterm neonates surviving in LICs are
increasing [1, 3]. Preterm and low birth weight (LBW)
neonates are at increased risk of intracranial bleeding,
specifically intraventricular haemorrhage (IVH), with
those < 32 weeks gestational age (GA) or < 1500 g at
highest risk [4, 5]. In high income countries (HICs), IVH
has been shown to contribute significantly to both mor-
tality and cognitive and motor neurological impairment
in premature and LBW neonates [4, 6–8]. However, data
regarding the incidence, risk factors and complications
of IVH in LICs are scarce [9–12]. This study on IVH is
one of the first studies in LBW neonates in sub-Saharan
Africa and the first in east Africa.
IVH is often divided into low and high grades, neuro-
developmental outcomes being different between these
two groupings. Low grade IVH is defined as bleeding
confined to the germinal matrix (Papile grade 1) or into
the lateral ventricle without causing dilatation (Papile
grade 2) [5]. High grade IVH is bleeding into the lateral
ventricle causing acute ventricular dilatation (Papile
grade 3) or IVH associated with periventricular haemor-
rhagic infarction (PVHI) (Papile grade 4) [5].
In HICs, the prevalence of IVH in neonates born
weighing < 1500 g is reported at 32%, with 16% of these
being high grade [13]. For neonates weighing up to
2200 g, 23% have IVH, 10.3% high grade [14]. When
assessed by GA, of those born at < 28 weeks GA, 32–
33.9% have IVH, 12.6–16% severe [13, 15, 16]. Neonates
born at < 32 weeks have reported IVH prevalence of
21.4–24.2, 7.7% high grade [14, 17, 18]. In HICs, high
grade IVH leads to cerebral palsy in about 30% of cases,
mainly but not only related to the site of parenchymal
haemorrhagic infarction, in addition to other develop-
mental and neurosensory impairments [16].
In HICs, many risk factors for IVH have been identi-
fied, including lack of antenatal maternal corticosteroids,
early sepsis, hypoglycaemia, respiratory distress syn-
drome (RDS), need for continuous positive airway pres-
sure (CPAP), lack of postnatal vitamin K administration,
hypothermia, male sex, maternal human immunodefi-
ciency virus (HIV) infection and patent ductus arteriosus
(PDA) [14, 17, 19–21]. Minimising these risk factors can
reduce the incidence of IVH, hence it is important to
identify the most influential and modifiable risk factors
in the population in question.
Evidence from HICs is not always generalisable to
LICs due to variations in population, perinatal exposures
and neonatal care. Thus the contribution of IVH to
death and disability in LICs warrants further
investigation [1]. This study aimed to examine the inci-
dence, severity and timing of IVH amongst LBW neo-
nates in Uganda and examine the impact of IVH on
neonatal survival. In addition, we aimed to identify
modifiable risk factors for IVH to inform the future de-
velopment of prevention strategies.
Methods
Study design
This was a prospective cohort study of neonates with
birthweights of ≤2000 g who were admitted to the neo-
natal unit (NU) at Mbale Regional Referral Hospital
(MRRH) in eastern Uganda.
Setting
MRRH serves a mixed urban and rural population of 4.5
million people. It has a dedicated NU that admits over
2500 neonates a year, including around 600 neonates
weighing ≤2000 g. Neonates are admitted from the
labour ward, surrounding health facilities and home.
MRRH-NU saw significant reduction in preterm mortal-
ity following implementation of a two-tiered hospital-
based neonatal care package [3]. Further reduction in
preterm mortality was achieved with the introduction of
bubble CPAP (bCPAP) [22]. The Ugandan National
Guidelines recommend antenatal steroids are given to
all women in threatened preterm or preterm labour and
intrapartum antibiotics are given to women with signs of
sepsis, chorioamnionitis or preterm premature rupture
of membranes (PPROM) but the practice is not ubiqui-
tous [23]. Vitamin K is available for administration at
delivery in MRRH and in the NU for those born else-
where who did not receive it. Neonates of < 27 weeks
GA receive palliative care. In the absence of adequate la-
boratory investigations, all neonates < 2000 g receive 7
days of postnatal antibiotics.
Participants
All neonates admitted to the NU weighing ≤2000 g be-
tween January and May 2019 were screened for eligibil-
ity. Parents or guardians were approached for informed,
written consent for enrolment. Inclusion criteria were i)
admission weight ≤ 2000 g, ii) < 72 h old at recruitment
iii) mother or guardian who spoke English, Luganda,
Lumasaba or Ateso iv) mother or guardian able to pro-
vide informed, written consent and v) infant alive at the
time of the recruitment scan. Exclusions included neo-
nates with major congenital anomalies and neonates
from multiple births where a sibling weighed > 2000 g.
Data sources and measurement
On admission, heart rate and oxygen saturations were
recorded using a Masimo™ Radical 7 pulse oximeter and
respiratory rate was measured manually. Axillary
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temperature was measured using an Omron™ digital
thermometer at admission and four times per day there-
after. Neonates were weighed using Seca™ electronic
scales. GA was assessed using the New Ballard assess-
ment [24]. Maternal medical history and demographics,
antenatal events and birth history were collected via a
structured interview with the mother and from obstetric
medical records at the point of recruitment. Neonatal
data regarding exposure to postnatal risk factors for IVH
and clinical outcomes were extracted from medical re-
cords up to day 28 or the time of death.
The following definitions were used:
– Respiratory distress: tachypnoea, sub-costal reces-
sions and nasal flaring within the first 4 h after birth.
– Haemodynamically significant PDA (hsPDA):
confirmed on echocardiogram and defined by the
presence of left atrium/ aortic root diameter > 1.5 in
the presence of continuous left to right shunting.
All neonates underwent a cranial ultrasound scan
(cUS) on the day of recruitment (< 72 h of age) and add-
itional scans on days three, seven and 28. Neonates who
were recruited on day three due to late presentation to
the unit or delivery outside of recruitment hours had
additional scans only on days seven and 28. If neonates
were discharged before day 28, they were called back for
their cUS. If the patient was reported to have died after
discharge, the date was confirmed by the parent or
guardian.
All scans were performed using a portable ultra-
sound machine (Sonosite M-Turbo®) with a C11x
curved probe (frequency 8–5 MHz) and a linear
probe (frequency 13–6 MHz). Standard images were
taken with the curved probe via the anterior fonta-
nelle in coronal and sagittal planes with additional
images taken via the mastoid and posterior fonta-
nelles [25]. The linear probe was used to obtain
colour Doppler images of venous sinuses. Scans were
performed by two clinical research fellows and the
lead neonatal doctor, all of whom were trained ei-
ther by United Kingdom trained consultant neona-
tologists or the MRRH lead neonatal doctor. Scans
were anonymised at the point of acquisition, stored
in a password protected cloud storage system, as was
all data, and centrally read by two consultant neona-
tologists with extensive experience in preterm neuro-
imaging. Assessors were blinded to all clinical details
of the neonate and images from each infant were
grouped together. Inter observer reliability between
the assessors was > 90%.
The images were examined for the presence and severity
of IVH, post-haemorrhagic ventricular dilatation (PHVD),
cystic periventricular leukomalacia (cPVL) [25], venous
sinus thrombosis, cerebellar haemorrhage (CBH), cysts,
pseudocysts, calcifications, lenticulostriate vasculopathy
(LSV) and anatomical abnormalities. Papile Grade 1–2 was
classified as low grade IVH, grade 3–4 as high grade [5].
Exposures and outcomes
Exposures included delivery type, resuscitation at deliv-
ery, resuscitation during admission, hypoxia (oxygen sat-
urations < 90%) at presentation, hypothermia in the first
24 h of admission (temperature < 36 °C), hsPDA, respira-
tory distress, bCPAP, being SGA (<10th centile of weight
for GA [26]), antenatal corticosteroids, outborn, multiple
pregnancy and maternal HIV. Outcomes included pres-
ence, severity, timing and complications of IVH includ-
ing PHVD and cPVL and neonatal mortality.
Statistical methods
A convenience sample of 120 neonates was recruited.
All statistical analyses were performed using the statis-
tical language R version 3.6.2 [27]. IVH and other ultra-
sound findings were reported as a proportion (%) of
neonates affected. Risk factors were tabulated and pre-
sented in frequencies and percentages. For Tables 4, 5
and Supplementary Table 1, unadjusted, adjusted odds
ratios (aOR) and 95% confidence intervals were calcu-
lated using logistic regression. The outcome of interest
was an IVH event and risk factors were the covariates of
interest. The aOR were estimated by adjusting for gesta-
tion and weight as continuous measures and sex as a
binary measure. Supplementary Table 2 presents un-
adjusted, adjusted odds ratios and 95% confidence inter-
vals on survival outcomes as a function of bleeds within
all neonates. Separately, odds ratios (OR) were calculated
when stratifying patients by low weight and gestational
status. When stratifying by weight and GA the respective
variables accounting for weight and GA were not in-
cluded. For rare risk factors containing zero cells in the
2 × 2 contingency table we applied Fishers’ exact test to
calculate unadjusted OR and 95% confidence intervals.
Results
During the 5-month study period, 839 neonates were ad-
mitted to MRRH-NU, 240 (28.6%) of whom weighed
≤2000 g and were screened for enrolment eligibility. In-
clusion criteria were fulfilled by 124 neonates and 120
were successfully recruited (Fig. 1). Table 1 shows their
baseline characteristics.
Incidence, severity and timing of IVH
Overall 34.2% (41/120) neonates had IVH of any sever-
ity, with 15% (18/120) having a high grade IVH (Table
2). Table 2 describes the severity of IVH seen according
to birth weight and gestational age. High grade IVH was
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more common amongst neonates of lower gestational
age and birth weight.
Of neonates who had IVH, 90.2% had occurred by day
7, including 88.9% of all high grade IVHs (Fig. 2). Re-
garding grade 4 IVH (PVHI), 42.9% (3/7) occurred by
day 1 and 14.3% (1/7) after day 7 (Fig. 2).
Cystic PVL (cPVL) was identified in three neonates
(2.5%), one with bilateral grade 3 cPVL on day one, two
on day 28, one with bilateral grade 3 cPVL and one uni-
lateral grade 2 cPVL (Table 3). None of the cases of
cPVL were associated with reported IVH. Other findings
and anatomical variants are shown in Table 3.
Risk factors for IVH
Table 4 shows risk factors associated with IVH. Ninety-
eight babies (81.7%) were born by vaginal delivery. At
birth 13 (11.3%) received resuscitation including bag and
mask ventilation and/or chest compressions. During ad-
mission, 10 neonates (8.3%) were resuscitated in the NU,
3 of whom had also been resuscitated at delivery. Fifty-
one (42.5%) babies were SGA. The majority of mothers
received no antenatal corticosteroids (55%), 40% re-
ceived 1 dose and only 5% of mothers received 2 doses
and (Table 4).
Tables 4, 5 and Supplementary Table 1 report crude
and adjusted ORs examining the association between
IVH and a range of perinatal exposures. Prior to adjust-
ment, resuscitation in the NU, vaginal delivery and use
of bCPAP were shown to increase the odds of IVH.
After adjustment for sex, weight and GA as described
above, vaginal delivery, GA < 32 weeks, resuscitation in
the NU and being SGA (<10th centile) were found to in-
crease the odds of having an IVH. The aOR for having
any IVH was 3.5 (95% CI 1.01–16.45), comparing vaginal
delivery with Caesarean delivery. Compared with neo-
nates of ≥32 weeks GA, neonates of GA < 32 weeks had
increased odds of any IVH, aOR 6.70 (95% CI 1.6–
31.02), high grade IVH, aOR 8.18 (95% CI 1.18–69.37),
and low grade IVH, aOR 6.70 (95% CI 1.12–46.9). Neo-
nates who required resuscitation in the NU also had in-
creased odds of any IVH, aOR 5.10 (95% CI 1.23–26.36)
and high grade IVH aOR 9.24 (95% CI 1.83–54.38). Neo-
nates who were SGA had increased odds of low grade
IVH, aOR 9.96 (95% CI 1.83–71.84). Birth weight < 1500
g, sex, use of bCPAP, hsPDA, respiratory distress, resus-
citation at delivery, hypoxia at presentation, hypothermia
in the first 24 h after birth, multiple pregnancy, maternal
HIV and not being born at the study site were not
Fig. 1 Flow chart of recruitment process, exclusions and outcomes
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shown to be associated with IVH after adjustment.
When considering neonates whose mothers received any
antenatal steroids, no relationship with IVH was demon-
strated. Of interest, no IVH of any severity was seen in
the subgroup of six infants whose mothers received 2
doses of steroids (see supplementary Table 3).
Outcomes at 28 days
Of the 120 neonates recruited, 34 (28.3%) died before
day 28. Twenty-eight (23.3%) died before discharge, in-
cluding 16 (13.3%) before day 7. An additional six (5%)
died after discharge. The majority, 79.4% (27/34), of neo-
nates who died weighed < 1500 g at birth. Five neonates
(4.2%) were lost to follow-up and 81 (70.4%) were seen
and had a day 28 cUS (Fig. 1). IVH was not found to be
an independent risk factor for death, even if severe (Sup-
plementary Table 2).
Discussion
This is one of the first studies of IVH in LBW neonates
in a LIC in sub-Saharan Africa and the first in east Af-
rica. We found that more than a third of neonates born
weighing ≤2000 g had any IVH and 15% had high grade
IVH. The majority of IVH had occurred by day 7. Vagi-
nal delivery, GA < 32 weeks, resuscitation in the NU and
being SGA (<10th centile) increased the odds of having
IVH.
Our findings show a higher prevalence of IVH than
two studies from Nigeria, but are comparable to one
study from Zambia. This prospective study of neonates
weighing < 1500 g found an IVH prevalence of 34.2%,
comparable to our finding of 38.7% [10]. Neonates were
only scanned up to day 7 however, and our study
showed 9.8% of IVH occurred after day 7. In contrast,
the studies from Nigeria, both of neonates < 1500 g
found lower rates of IVH. One found a 24.1% prevalence
of IVH, however each infant was only scanned once
within the first week (range 60 h to 7 days) [9]. The sec-
ond found 29.7% had IVH, 7.5% of which were high
grade [12]. This is likely to be an underestimation as
many eligible neonates were not scanned as they died
within 72 h of birth. No studies in LICs in sub-Saharan
Africa have examined IVH in neonates weighing 1500-
2000 g. Our data showing that in this subgroup almost
one in three have IVH and one in 10 have high grade
IVH are therefore the first in this area.
On analysis by gestation, in neonates of 28–31
weeks GA we found rates of IVH of 31.6%, compar-
able with findings from another Nigerian study of
33.3% [11]. However, in the 32–42 week GA group
we found much higher rates (34.2% vs 6.3%). Of note,
this study had much lower rates of SGA neonates
than ours (21.8% vs 42.5%) which may contribute to





< 1000 9 (7.5)
1000–1499 53 (44.2)
1500–2000 58 (48.3)
Mean (± SD) 1463 ± 310
Gestation (weeks) (New Ballard assessment)
















Vaginal Cephalic 93 (77.5)
Vaginal Breech 5 (4.2)
Emergency Caesarean 22 (18.3)




District Hospital 10 (8.3)
Health Centre 27 (22.5)
Private Clinic 7 (5.8)
Home 9 (7.5)
On the way to hospital 3 (2.5)
Antenatal steroids
None 61 (50.8)
1 dose 48 (40.0)
2 doses 6 (5)
Unknown 5 (4.2)
Age at scan n, (Median, range)
Day 1 88 (2, 1–3)
Day 3 106 (3, 2–5)
Day 7 97 (7, 6–10)
Day 28 71 (33, 24–87)
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this difference, although the relationship of SGA with
IVH varies between studies [28, 29].
Overall and in all subgroups for any IVH and high
grade IVH, our rates are higher than in HICs. The
difference is smallest in the < 1500 g and < 28 week
gestation groups and largest in neonates of > 1500 g
or > 37 weeks, suggesting in our setting the higher
weight and GA neonates may benefit most from
modification of risk factors [13, 14, 16, 18, 30].
Our results show that 34% of all IVH had occurred
on day 1, 58.5% by day 3 and 90.2% by day 7. In the
Zambian study, 68.7% of IVH had occurred by 72 h
of age, however as they only scanned up to day 7 this
may be an overestimation of the total proportion
[10]. Evidence from HICs shows that approximately
50% of IVHs occur in the first 24 h after birth and al-
most all by 72 h [31]. This could be due to different
aetiologies for IVH in our settings, with more influ-
ence from postnatal risk factors due to the standard
of neonatal care available.
Our results show that neonates with GA of < 32
weeks had increased odds of having both mild and
severe IVH, in keeping with other studies from HICs
and LICs [9–11, 13, 20, 32]. Birthweight was not
shown to be associated with IVH, which is contrary
to most findings from HICs but in keeping with some
studies in Africa [5, 11, 12, 19]. This lack of associ-
ation of weight with IVH is possibly due to the high
prevalence of SGA neonates (42.5%) giving a higher
GA than expected for birthweight, thus comparatively
reducing risk of IVH.
Vaginal delivery was associated with increased odds of
IVH compared with Caesarean delivery. It was not
shown to be associated with low grade IVH, however the
Table 2 Frequency, severity of intraventricular haemorrhage n, (%)




All neonates ≤ 2000 g
n = 120





No haemorrhage 38 (61.3) 41 (70.7) 79 (65.8) 27 (65.9) 50 (65.8)
Any haemorrhage 24 (38.7) 17 (29.3) 41 (34.2) 14 (31.6) 26 (34.1)
Grade 1 5 (8.1) 5 (8.6) 10 (8.3) 2 (4.9) 7 (9.2)
Grade 2 8 (12.9) 5 (8.6) 13 (10.8) 4 (10.4) 9 (11.8)
Grade 3 8 (12.9) 3 (5.2) 11 (9.2) 4 (9.8) 7 (9.2)
Grade 4 3 (4.8) 4 (6.9) 7 (5.8) 4 (10.5) 3 (3.9)
a3 neonates did not have a Ballard score recorded
Fig. 2 Cumulative timing of IVH by severity for all cases of IVH
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sample was too small to determine the relationship with
high grade IVH. Whilst vaginal delivery is a recognised
risk factor for high grade IVH in HICs, this finding has
not been replicated in studies from LICs in sub-Saharan
Africa [9–11, 33, 34]. This may be related to the timing
and indications for Caesarean differing.
Resuscitation in the NU was associated with an in-
creased probability of any IVH and high grade IVH. Re-
suscitation at birth is a risk factor for IVH however this
was not demonstrated in our results [35]. This is likely
due to poor documentation and limited accessibility of
adequate neonatal resuscitation. We found that the
prevalence cPVL (2.4%) was comparable with expected
rates from HICs; there are no comparable data currently
available from LICs in Africa [36].
We found that SGA neonates had increased odds of
low grade IVH, however this finding should be inter-
preted with caution. Comparable studies in LICs in
sub-Saharan Africa found no association with SGA
and IVH, and in HICs the relationship of SGA with
IVH varies between studies [11, 12, 28, 29]. Whilst
our study had both a larger sample size and much
higher rates of SGA than other African studies which
may explain why we identified an association, this
finding is not supported by any relationship with high
grade IVH [11, 12]. Low grade IVH can be difficult
to detect using cUS, so it is possible that some were
missed in these studies [37]. Many risk factors for
SGA are present in our population, including mater-
nal malnutrition, infections and PET and their preva-
lence and relationship with IVH in this setting is an
area of future interest [38].
Whilst no relationship between exposure to 1 or 2
doses of antenatal steroids and IVH was shown
Table 3 Frequency of non-IVH ultrasound findings n, (%)
Absent septum pellucidum 1 (0.8)
Calcifications 1 (0.8)
Cerebellar haemorrhage 2 (1.7)
Choroid plexus cyst 17 (14.2)
Cystic PVL Grade 2 1 (0.8)
Cystic PVL Grade 3 2 (1.7)
Lenticulostriate vasculopathy 20 (16.7)
Post haemorrhagic ventricular dilation 2 (1.7)
Pseudocysts 12 (10)
Signs of hypoxic injury 1 (0.8)
Subarachnoid haemorrhage 2 (1.7)
Venous sinus thrombosis 2 (1.7)
Table 4 Risk factors associated with IVH in univariable and multivariable analysis (N = 120)








Unadjusted OR (95% CI) Adjusted OR (95% CI)
Antepartum
Multiple pregnancy 47 (39.2) 34 (43.0) 13 (31.7) 0.61 (0.27–1.3) 0.54 (0.23–1.22)
Maternal HIV 7 (5.8) 3 (3.8) 4 (9.8) 2.59 (0.54–13.76) 1.90 (0.38–10.41)
Antepartum steroids (2 doses) 6 (5.0) 6 (7.6) 0 (0) 0 (0–6.19) 0 (0–1.05)
Antepartum steroids (any doses) 54 (45) 39 (49.4) 15 (36.6) 0.55 (0.25–1.20) 0.63 (0.27–1.47)
Intrapartum
Vaginal delivery 98 (81.7) 60 (75.9) 38 (92.7) 4.011 (1.26–17.89) 3.50 (1.01–16.45)
Outborn 56 (46.7) 39 (49.4) 17 (41.5) 1.376 (0.65–2.98) 1.87 (0.80–4.57)
Neonatal
Male 60 (50.0) 41 (52.9) 19 (346.3) 0.80 (0.37–1.70) 0.69 (0.15–3.12)
Admission weight < 1500 ga 62 (51.7) 38 (48.1) 24 58.5) 1.52 (0.71–3.30) 0.67 (0.15–2.93)
Gestation < 32 weeksb 41 (34.2) 27 (34.2) 14 (34.1) 1.00 (0.45–2.27) 6.70 (1.6–31.02)
SGA (<10th centile) 51 (42.5) 33 (41.8) 18 (43.9) 1.09 (0.50–2.36) 2.6 (0.79–9.42)
Resuscitation at delivery 13 (10.8) 11 (13.9) 2 (4.9) 0.32 (0.05–1.26) 0.36 (0.05–1.47)
Resuscitation in NU 10 (8.3) 3 (3.8) 7 (17.1) 5.22 (1.36–25.34) 5.10 (1.23–26.36)
Respiratory distress within 4 h of admission 49 (40.8) 29 (36.7) 20 (48.8) 1.64 (0.76–3.55) 1.43 (0.581–3.48)
bCPAP 38 (31.7) 20 (25.3) 18 (43.9) 2.31 (1.04–5.17) 2.09 (0.84–5.27)
hsPDA 20 (16.7) 10 (12.7) 10 (24.4) 2.23 (0.83–5.97) 1.89 (0.68–5.24)
Hypothermia (< 36 degrees) in 1st 24 h 84 (70.0) 53 (67.1) 31 (75.6) 1.46 (0.63–3.56) 1.17 (0.45–3.16)
Hypoxia (< 90% saturation in air) at presentation 47 (39.2) 31 (39.2) 16 (39.0) 0.99 (0.45–2.15) 1.00 (0.43–2.33)
aAdjusted for sex and gestational age, badjusted for sex and weight. All other variables adjusted for sex, gestational age and weight
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possibly due to the small sample, of the 6 neonates
who received 2 doses of antenatal steroids, none had
IVH. Interestingly, this group had few additional risk
factors for IVH (see Supplementary Table 3). Ante-
natal corticosteroids are protective against IVH in
HICs, however current evidence suggests that in LICs
antenatal steroids can increase the risk of neonatal
death [14, 39, 40]. Although it is possible that the
low rates of steroid exposure in our study (only 47%)
may have contributed to the high rates of IVH, fur-
ther data on the impact of antenatal steroids on IVH
and other preterm complications are needed; use of
antenatal steroids in this setting remains controversial
and needs further exploration.
We did not find IVH to be an independent predictor
of survival. There is little evidence on survival after IVH
in LICs, but in this cohort there was a much lower mor-
tality in neonates with IVH than in a Nigerian study
(41.7% vs 66.7%) [9]. This is likely due to the relatively
high standard of care at our centre [22].
Over a quarter of neonates in the study died by day
28, the large majority before discharge. Of neonates
≤2000 g who had IVH, a third died, compared with a
quarter of those who did not, a difference not found to
be statistically significant. Of the neonates that died,
more than three quarters weighed < 1500 g and of neo-
nates weighing < 1500 g, just under half died, findings
which are in keeping with data from a meta-analysis of
neonatal mortality in East Africa [41].
Strengths of this study included that the cUS were per-
formed by well-trained investigators and that image ana-
lysis was undertaken prospectively and independently by
2 blinded, experienced, senior clinicians. Outcomes are
known for a high proportion of participants (115/120,
95.8%) and 71/81 (87.7%) babies alive at day 28 under-
went a day 28 cUS.
Limitations include challenges with reliable capture of
obstetric and perinatal data. Additionally, 26 neonates
died very early before recruitment, to which IVH could
have contributed, therefore the occurrence, particularly
of severe IVH may be underestimated. This could also
cause an underestimation in the mortality associated
with IVH. Furthermore, 10/81 surviving neonates
(12.3%) were unable to attend for day 28 scans so it is
possible that some findings such as cPVL were underes-
timated. Due to the date of women’s last menstrual
period being rarely known, assessment of GA was by
Ballard scoring which is accurate to +/− 2 weeks and has
inter user variability. The assessment of haemodynamic
significant of PDA was made using only LA/Aortic root
Table 5 Risk factors associated with high grade IVH in univariable and multivariable analysis (N = 97)










Adjusted OR (95% CI)
Antepartum
Multiple pregnancy 39 (40.2) 34 (43.0) 5 (27.8) 0.51 (0.15–1.49) 0.41 (0.12–1.27)
Maternal HIV 6 (6.2) 3 (3.8) 3 (16.7) 4.67 (0.80–27.46) 3.08 (0.48–19.38)
Antepartum steroids (2 doses) 6 (6.2) 6 (7.6) 0 0 (0–3.58) 0 (0–4.51)
Antepartum steroids (any doses) 46 (47.4) 39 (49.4) 7 (38.9) 0.59 (0.20–1.66) 0.835 (0.26–2.66)
Intrapartum
Vaginal delivery 78 (80.4) 60 (75.9) 18 (100.0) 6.15 (0.86–271.26) –
Outborn 46 (47.4) 39 (49.4) 7 (38.9) 1.53 (0.55–4.55) 3.01 (0.92–11.03)
Neonatal
Male 51 (52.6) 41 (52.9) 10 (55.6) 1.16 (0.41–3.33) 1.73 (0.21–15.49)
Admission weight < 1500 ga 49 (50.5) 38 (48.1) 11 (61.1) 1.70 (0.61–5.03) 2.25 (0.26–20.59)
Gestation < 32 weeksb 35 (36.1) 27 (34.2) 8 (44.4) 0.68 (0.24–1.96) 8.18 (1.18–69.37)
SGA (<10th centile) 37 (38.1) 33 (41.8) 4 (22.2) 0.38 (0.10–1.18) 0.81 (0.14–4.36)
Resuscitation at delivery 13 (13) 11 (13.9) 2 (11.1) 0.77 (0.11–3.26) 1.19 (0.16–5.72)
Resuscitation in NU 8 (8.2) 3 (3.8) 5 (27.8) 9.74 (2.14–52.4) 9.24 (1.83–54.38)
Respiratory distress within 4 h of admission 39 (40.2) 29 (36.7) 10 (55.6) 2.16 (0.77–6.24) 1.78 (0.52–6.16)
bCPAP 29 (29.9) 20 (25.3) 9 (50.0) 2.95 (1.92–8.60) 2.28 (0.67–7.77)
hsPDA 15 (15.5) 10 (12.7) 5 (27.8) 2.65 (0.73–8.86) 2.36 (0.62–8.45)
Hypothermia (< 36 degrees) in 1st 24 h 69 (71.1) 53 (67.1) 16 (88.9) 3.77 (0.97–25.03) 3.84 (0.87–27.67)
Hypoxia (< 90% saturation in air) at presentation 41 (42.3) 31 (39.2) 10 (55.6) 2.12 (0.74–6.41) 2.01 (0.64–6.51)
a Adjusted for sex and gestational age, b adjusted for sex and weight. All other variables adjusted for sex, gestational age and weight
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diameter as measurement of other parameters of haemo-
dynamic significance were not available, therefore it is
possible that may have been underestimated in some ne-
onates due to offloading of the LA through a patent for-
amen ovale. Assessing potential risk factors for IVH was
a secondary analysis and therefore the sample size may
have been too small to determine relationships for some
risk factors. Additionally, clinical data was collected
retrospectively from the medical notes.
Conclusion
This study found that in this resource limited NU in a re-
gional referral hospital in eastern Uganda, more than a
third of neonates born weighing ≤2000 g had an IVH and
majority of these occurred by day 7. We found that vaginal
delivery, GA < 32weeks, resuscitation in the NU and be-
ing SGA (<10th centile) were associated with increased
odds of having an IVH. This study had a high rate of SGA
neonates and the risk factors and relationship of these
with IVH in this setting needs further investigation. The
role of antenatal steroids in the prevention of IVH in LICs
also needs urgent exploration.
Supplementary Information






aOR: adjusted odds ratio; APH: Antepartum haemorrhage; bCPAP: bubble
continuous positive airway pressure; CPAP: Continuous positive airway
pressure; cPVL: cystic periventricular leukomalacia; cUS: cranial ultrasound
scan; GA: Gestational age; HIC: High income country; HIV: Human
immunodeficiency virus; hsPDA: haemodynamically significant patent ductus
arteriosus; IVH: Intraventricular haemorrhage; KMC: Kangaroo mother care;
LA: Left atrium; LBW: Low birth weight; LIC: Low income country; LOS: Late
onset sepsis; MRRH: Mbale regional referral hospital; NEC: Necrotising
enterocolitis; NU: Neonatal unit; OR: Odds ratio; PDA: Patent ductus
arteriosus; PET: Pre-eclampsia; PHVD: Post haemorrhagic ventricular dilatation;
pPROM: preterm prolonged rupture of membranes; PVHI: Periventricular
haemorrhagic infarction; PVL: Periventricular leukomalacia; RDS: Respiratory
distress syndrome; SSS: Superior sagittal sinus; SVD: Spontaneous vaginal
delivery
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